SURGICAL SPECIALTY CENTER OF BATON R — History
CCN 190251 | 3-year financial timeline | COVID resilience: 30/100
🛡️ Public data only — no PHI permitted on this instance.
$50M
Latest Revenue (FY2022)
-2.4%
Revenue CAGR (3yr)
16.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $52M | $54M | $50M | -8.6% | -2.4% |
| Operating Expenses | $37M | $41M | $41M | +2.2% | +5.2% |
| Operating Margin | 28.4% | 25.6% | 16.9% | -34.2% | -23.0% |
| Net Income | $15M | $14M | $8M | -39.8% | -24.8% |
| Licensed Beds | 16 | 16 | 16 | +0.0% | +0.0% |
| Total Patient Days | 975 | 719 | 552 | -23.2% | -24.8% |
| Medicare Day % | 19% | 21% | 26% | +25.0% | +14.9% |
| Medicaid Day % | 1% | 1% | 1% | -44.2% | -27.2% |
COVID Impact & Recovery
Resilience Score: 30/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -4.7% ($52M → $50M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-2.4%
This Hospital
+7.6%
State Avg
Latest Margin
16.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $49M | 11.1% |
| FY2024 (proj) | $47M | 5.3% |
| FY2025 (proj) | $46M | -0.5% |